Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single ascending dose study of Procizumab (AK1967) versus placebo in healthy male volunteers
NL-OMON59848Phase 1Completed
- Sponsor
- 4TEEN4 Pharmaceuticals
- Start
- Mar 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Shock comparing Procizumab with Placebo (2 arms). Primary endpoint: Primary endpoint(s). Started Mar 2024; status: completed.
02
Drugs
invobenitug
03
Conditions
Shock
Beyond the preview
Go deeper on NL-OMON59848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59848.